CN Patent

CN113365631B — 布鲁顿酪氨酸激酶抑制剂

Assigned to Hangzhou Bangshun Pharmaceutical Co Ltd · Expires 2024-08-30 · 2y expired

What this patent protects

具有下式(I)或(II)的布鲁顿酪氨酸激酶(BTK)抑制剂。

USPTO Abstract

具有下式(I)或(II)的布鲁顿酪氨酸激酶(BTK)抑制剂。

Drugs covered by this patent

Patent Metadata

Patent number
CN113365631B
Jurisdiction
CN
Classification
—
Expires
2024-08-30
Drug substance claim
No
Drug product claim
No
Assignee
Hangzhou Bangshun Pharmaceutical Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.